Redeye: CTEK - A minor bump in the road
21 juli, 09:10
21 juli, 09:10
Redeye updates its estimates and fair value range following CTEK’s Q2 report, which was released last week. We think the report was somewhat softer than expected, although largely in line with our estimates, where macroeconomic turbulence dented the short-term growth curve. However, we think that the investment case remains equally intact following the report, and we look forward to seeing CTEK launching its adjacent product categories in H2 2025.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
21 juli, 09:10
Redeye updates its estimates and fair value range following CTEK’s Q2 report, which was released last week. We think the report was somewhat softer than expected, although largely in line with our estimates, where macroeconomic turbulence dented the short-term growth curve. However, we think that the investment case remains equally intact following the report, and we look forward to seeing CTEK launching its adjacent product categories in H2 2025.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments

Analys
Saab kammar hem miljardordrar

Guldrallyt
Fonder

Bolån



Analys
Saab kammar hem miljardordrar

Guldrallyt
Fonder

Bolån


1 DAG %
Senast
Styrränta
26 december, 07:00
Storbankernas prognoser: Så gör Riksbanken 2026
Qualisys
26 december, 07:00
Qualisys är en aktie för dig som gillar småbolag
SBB Norden D
25 december, 07:00
Reportagen från 2025 du inte får missa
OMX Stockholm 30
1 DAG %
Senast
2 849,09